https://www.healthnewsofalabama.com/article/912578977-chengdu-origen-and-vanotech-announce-khn921-investigational-new-drug-application-clearance-by-the-us-fda-for-the-treatment-of-hypertrophic Health News of Alabama en PressRelease 2026-05-13T18:09:42+00:00 Chengdu Origen and Vanotech Announce KHN921 Investigational New Drug application clearance by the US FDA for the treatment of hypertrophic cardiomyopathy (HCM) associated with MYBPC3 mutations https://ml.globenewswire.com/media/ZDU3YzMzYmYtZGNkMC00ODQ1LTg0OGYtYmYxZTY2Mzc3ZWI0LTEyNzYwMTEtMjAyNi0wNS0xMy1lbg==/tiny/Vanotech-Ltd.png https://www.healthnewsofalabama.com/article/912578938-nasp-releases-agenda-for-the-inspire2026-conference Health News of Alabama en PressRelease 2026-05-13T17:43:35+00:00 NASP Releases Agenda for the inSPire2026 conference https://ml.globenewswire.com/media/ZTJhYzg5ZTgtZjU0YS00NjQ0LWIwMmItNGQ5Yjk5ZGQ1MzQxLTEyMTc1MTEtMjAyNi0wNS0xMy1lbg==/tiny/National-Association-of-Specia.png https://www.healthnewsofalabama.com/article/912578557-ab-science-reports-its-revenues-for-the-year-2025-and-provides-an-update-on-its-activities Health News of Alabama en PressRelease 2026-05-13T17:36:33+00:00 AB Science reports its revenues for the year 2025 and provides an update on its activities https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/logo-jpg.jpg https://www.healthnewsofalabama.com/article/912578574-ab-science-annonce-ses-r-sultats-financiers-annuels-arr-t-s-au-31-d-cembre-2025-et-pr-sente-un-point-sur-ses-activit-s Health News of Alabama en PressRelease 2026-05-13T17:36:33+00:00 AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2025 et présente un point sur ses activités https://ml-eu.globenewswire.com/media/90d86a0e-7ea1-47ab-99d9-69985fa76ce0/small/ https://www.healthnewsofalabama.com/article/912578709-javatide-claims-evaluated-investigating-the-java-tide-ingredients-for-purity-and-potency Health News of Alabama en PressRelease 2026-05-13T17:01:03+00:00 JavaTide Claims Evaluated: Investigating the Java Tide Ingredients for Purity and Potency https://zingfast.com/wp-content/uploads/2026/05/JavaTide.jpg https://www.healthnewsofalabama.com/article/912578698-access-to-pet-care-shouldn-t-depend-on-housing-new-program-launches-in-canada Health News of Alabama en PressRelease 2026-05-13T17:00:55+00:00 Access to Pet Care Shouldn’t Depend on Housing: New Program Launches in Canada https://ml.globenewswire.com/media/f26926a5-47cf-47b0-b619-6352011dfd34/small/cvo-logo-header-png.png https://www.healthnewsofalabama.com/article/912556155-comprehensive-healthcare-names-new-coo-and-chro-to-strengthen-growing-organization Health News of Alabama en PressRelease 2026-05-13T16:00:00+00:00 Comprehensive Healthcare Names New COO and CHRO to Strengthen Growing Organization https://ml.globenewswire.com/media/301839b7-96c3-48b6-84df-efa9e34bcd65/medium/kamran-khatri-coo-at-comprehensive-healthcare.jpeg https://www.healthnewsofalabama.com/article/912558041-berry-street-partners-with-factor-bringing-personalized-nutrition-therapy-to-leading-meal-delivery-service Health News of Alabama en PressRelease 2026-05-13T16:00:00+00:00 Berry Street Partners with Factor, Bringing Personalized Nutrition Therapy to Leading Meal Delivery Service https://ml.globenewswire.com/media/1f33a9d2-0940-4ac0-a22f-f5eb55e6a2c0/small/image-png.png https://www.healthnewsofalabama.com/article/912558336-onward-medical-announces-results-of-the-2026-annual-general-meeting-of-shareholders Health News of Alabama en PressRelease 2026-05-13T15:57:15+00:00 ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders https://ml.globenewswire.com/media/a60261ec-0c66-4acb-8726-e567073990a2/small/onwardresized1-png.png https://www.healthnewsofalabama.com/article/912556277-biorestorative-therapies-presents-new-preclinical-data-at-isct-2026-highlighting-source-specific-exosome-functionality-and-commercial-applications-in Health News of Alabama en PressRelease 2026-05-13T15:00:00+00:00 BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png https://www.healthnewsofalabama.com/article/912557998-4-endodontist-approved-tips-to-help-save-your-natural-teeth Health News of Alabama en PressRelease 2026-05-13T14:41:51+00:00 4 Endodontist-Approved Tips to Help Save Your Natural Teeth https://ml.globenewswire.com/Resource/Download/83d1be1b-1786-4909-8ffa-2942fbb58214/17911-1.jpg https://www.healthnewsofalabama.com/article/912533976-tekniplex-healthcare-to-present-recyclable-blister-packaging-solutions-at-the-pharma-days-2026 Health News of Alabama en PressRelease 2026-05-13T14:22:45+00:00 TekniPlex Healthcare to Present Recyclable Blister Packaging Solutions at The Pharma Days 2026 https://ml.globenewswire.com/media/3f251057-b5c4-4c9e-8bfb-00d985da1514/medium/blister.jpg https://www.healthnewsofalabama.com/article/912533881-ama-survey-prior-authorization-reform-pledge-falls-short-with-physicians Health News of Alabama en PressRelease 2026-05-13T14:15:33+00:00 AMA Survey: Prior Authorization Reform Pledge Falls Short with Physicians https://ml.globenewswire.com/media/YzM5NzhiOGUtM2Y5ZC00NWM0LTg0ZTktNGZkZjQ5MWFlYTMyLTEwOTg0MDUtMjAyNi0wNS0xMy1lbg==/tiny/American-Medical-Association.png https://www.healthnewsofalabama.com/article/912533866-consumers-choose-bottled-water-first-10th-year-in-a-row Health News of Alabama en PressRelease 2026-05-13T14:14:11+00:00 Consumers Choose Bottled Water First – 10th Year in a Row! https://ml.globenewswire.com/media/ZTM4OWNiN2UtNGI4YS00MDY2LThhMjMtY2ExZmM3NGMyZWE5LTExMDQ5MDgtMjAyNi0wNS0xMy1lbg==/tiny/International-Bottled-Water-As.png https://www.healthnewsofalabama.com/article/912532712-eric-palmer-joins-amn-healthcare-board-of-directors Health News of Alabama en PressRelease 2026-05-13T14:02:00+00:00 Eric Palmer Joins AMN Healthcare Board of Directors https://ml.globenewswire.com/media/7ac9ce26-e0ee-41e1-94d5-cf8155014873/small/large-amn-logo-wtagline-jpg.jpg https://www.healthnewsofalabama.com/article/912533301-sapu-nano-announces-first-patient-dosed-in-phase-1b-trial-of-sapu003-an-intravenous-deciparticle-formulation-of-everolimus Health News of Alabama en PressRelease 2026-05-13T14:00:00+00:00 Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.healthnewsofalabama.com/article/912532745-usosm-secures-partnership-with-hudson-valley-oral-surgery Health News of Alabama en PressRelease 2026-05-13T13:47:00+00:00 USOSM Secures Partnership with Hudson Valley Oral Surgery https://ml.globenewswire.com/media/9472c27c-8b6d-4c87-95fd-31f1f0140263/small/usosm-logo-png.png https://www.healthnewsofalabama.com/article/912533554-noted-vaccine-researchers-u-ur-ahin-and-zlem-t-reci-awarded-sabin-vaccine-institute-s-albert-b-sabin-gold-medal-genomic-scientist-senjuti-saha-of Health News of Alabama en PressRelease 2026-05-13T13:41:04+00:00 Noted Vaccine Researchers Uğur Şahin and Özlem Türeci Awarded Sabin Vaccine Institute’s Albert B. Sabin Gold Medal; Genomic Scientist Senjuti Saha of Bangladesh Receives Rising Star Award https://ml.globenewswire.com/media/4edff3d3-064b-408f-a6fb-b2d48107b8de/medium/2026-sabin-rising-star-gold-medal-awardees.jpg https://www.healthnewsofalabama.com/article/912533537-75-years-of-care-leading-chinese-women-s-hospital-innovating-for-women-children-worldwide Health News of Alabama en PressRelease 2026-05-13T13:33:23+00:00 75 Years of Care: Leading Chinese Women's Hospital Innovating for Women, Children Worldwide https://ml.globenewswire.com/media/ZDFhZDU5NDYtZTA0Mi00YzJhLTkxYmUtMjFhMTJjZjhiODVjLTUwMDE2MjQ4Ni0yMDI2LTA1LTEzLWVu/tiny/Women-s-Hospital-School-of-Med.png https://www.healthnewsofalabama.com/article/912533316-polyrizon-advances-towards-human-clinical-trials-secures-first-u-s-clinical-site-for-nasarix-allergy-blocker-clinical-trial Health News of Alabama en PressRelease 2026-05-13T13:25:00+00:00 Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial https://ml.globenewswire.com/media/ZGQ3ZjE1MTQtZWIyMi00NjE4LWE4N2QtNzRjYzQ4YzMxZTRlLTUwMDEyOTIyMy0yMDI2LTA1LTEzLWVu/tiny/Polyrizon-Ltd-.png https://www.healthnewsofalabama.com/article/912533516-onconetix-reports-q1-2026-progress-at-proteomedix-ag-including-two-new-peer-reviewed-publications-and-initiation-of-u-s-validation-study Health News of Alabama en PressRelease 2026-05-13T13:25:00+00:00 Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study https://ml.globenewswire.com/media/4824d51d-2ecb-4f49-8b75-fe9b920e7b1c/small/onconetix-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912533290-safespace-global-corp-otcid-ssgc-to-participate-in-nashville-ai-week-president-cso-dustin-hillis-scheduled-for-multiple-speaking-engagements Health News of Alabama en PressRelease 2026-05-13T13:15:00+00:00 SafeSpace Global Corp. (OTCID: SSGC) to Participate in Nashville AI Week; President & CSO Dustin Hillis Scheduled for Multiple Speaking Engagements https://ml.globenewswire.com/media/e95639ca-a47d-4c90-a44e-cf8a03b6a6d2/small/logo-jpg.jpg https://www.healthnewsofalabama.com/article/912532914-the-plastic-crisis-is-exploding-and-kraig-biocraft-laboratories-has-a-unique-answer Health News of Alabama en PressRelease 2026-05-13T13:05:00+00:00 The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer https://ml.globenewswire.com/media/N2IwNDExZjMtMjkxZC00YzhmLTg5YzAtNGRhMzQwMGJhMWRkLTUwMDE1MTA3NC0yMDI2LTA1LTEzLWVu/tiny/24-7-Market-News-and-Kraig-Lab.png https://www.healthnewsofalabama.com/article/912532442-chemed-corporation-to-present-at-the-2026-rbc-global-healthcare-conference Health News of Alabama en PressRelease 2026-05-13T13:00:00+00:00 Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference https://ml.globenewswire.com/media/1ab951c0-8d76-40e0-bc65-ebeaa1731e66/small/chemed-corp-logo-600x400-jpg.jpg https://www.healthnewsofalabama.com/article/912532830-neomorph-appoints-biopharma-leader-robert-j-hugin-as-chairman-of-the-board Health News of Alabama en PressRelease 2026-05-13T13:00:00+00:00 Neomorph Appoints Biopharma Leader Robert J. Hugin as Chairman of the Board https://ml.globenewswire.com/media/d00180c1-5def-41b6-95c7-018ca5e07565/small/neomorph-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912532898-sharecare-joins-innovators-network-at-american-heart-association-center-for-health-technology-innovation Health News of Alabama en PressRelease 2026-05-13T13:00:00+00:00 Sharecare joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation https://ml.globenewswire.com/media/ab8cd27b-be52-406c-96ee-1a905002590b/small/new-logo-jpeg.jpeg https://www.healthnewsofalabama.com/article/912532925-femasys-expands-fertility-care-portfolio-in-europe-with-ce-mark-approval-for-femhsg-catheter Health News of Alabama en PressRelease 2026-05-13T13:00:00+00:00 Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter https://ml.globenewswire.com/media/c668c3db-ff7f-4eb5-b51a-b8db25e838b4/small/femasys-logo-2-jpg.jpg https://www.healthnewsofalabama.com/article/912533182-vicarious-surgical-demonstrates-sustained-system-performance-and-complex-hernia-procedure-workflows-in-pre-clinical-setting Health News of Alabama en PressRelease 2026-05-13T13:00:00+00:00 Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting https://ml.globenewswire.com/media/MzM2MmFiNjItZDU1Yi00MTdiLTkyYTctNTk1ZmMxODcwNjYwLTEyMTM5OTQtMjAyNi0wNS0xMy1lbg==/tiny/Vicarious-Surgical.png https://www.healthnewsofalabama.com/article/912533408-biofrontera-launches-second-annual-hats-on-campaign-to-raise-awareness-of-actinic-keratosis Health News of Alabama en PressRelease 2026-05-13T13:00:00+00:00 Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis https://ml.globenewswire.com/media/4af5197e-340e-4307-892b-382a1d29ae45/small/logo-png.png https://www.healthnewsofalabama.com/article/912532862-cannabix-marijuana-breath-test-achieves-major-milestone-breath-collection-unit-secures-ul-and-csa-certifications Health News of Alabama en PressRelease 2026-05-13T12:45:00+00:00 Cannabix Marijuana Breath Test Achieves Major Milestone: Breath Collection Unit Secures UL and CSA Certifications https://ml.globenewswire.com/media/c34b09c2-586a-4678-a896-54bf9c06cb73/medium/cannabix-technologies-inc.jpg https://www.healthnewsofalabama.com/article/912533342-anteris-appoints-susan-knight-and-stephen-denaro-to-its-board-of-directors Health News of Alabama en PressRelease 2026-05-13T12:39:40+00:00 Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors https://ml.globenewswire.com/media/90a5ae8d-7cf0-4a3d-b38c-f4ad7e3fbf0e/small/anteris-tech-rgb-blue-png.png https://www.healthnewsofalabama.com/article/912532630-aware-announces-successful-independent-evaluation-of-intelligent-liveness-aligned-with-cen-ts-18099 Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Aware Announces Successful Independent Evaluation of Intelligent Liveness Aligned with CEN/TS 18099 https://ml.globenewswire.com/media/a04f465c-3b1c-4f2a-a547-3fcb543ddaa2/small/aware-logo-for-press-releases-jpg.jpg https://www.healthnewsofalabama.com/article/912532659-bicara-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/fdf5e06f-0748-428a-8f90-b0a1c6f7bdf3/small/bicara-logo-struck-png.png https://www.healthnewsofalabama.com/article/912532749-amlogenyx-presents-preclinical-data-on-am805-a-potentially-transformative-investigational-gene-therapy-for-alzheimer-s-disease Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Amlogenyx Presents Preclinical Data on AM805, a Potentially Transformative Investigational Gene Therapy for Alzheimer’s Disease https://ml.globenewswire.com/media/bf40d975-ac7e-4fef-b836-08a561a7c6ee/small/amlogenyx-logo-png.png https://www.healthnewsofalabama.com/article/912532759-rectify-pharmaceuticals-to-present-preclinical-data-on-new-dual-targeted-abcb4-bsep-positive-functional-modulator-at-easl-2026 Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026 https://ml.globenewswire.com/media/bdac6aa0-18b4-4330-98a1-e9673a671b69/small/rectify-logo-color-jpg.jpg https://www.healthnewsofalabama.com/article/912532765-ss-innovations-reports-first-quarter-2026-financial-results Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 SS Innovations Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/cef267e0-040f-4889-a706-cc4d0ae49e55/small/new-logo-april-23-2025-png.png https://www.healthnewsofalabama.com/article/912532801-nexgel-appoints-dave-hazard-as-vice-president-of-sales-for-bionx-surgical Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://www.healthnewsofalabama.com/article/912532855-pharmala-biotech-executes-definitive-agreement-to-form-special-purpose-vehicle-restora-neurosciences-for-clinical-development-of-patented-novel-mdxx Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01 https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png https://www.healthnewsofalabama.com/article/912532864-fate-therapeutics-reports-first-quarter-2026-financial-results-and-business-updates Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://www.healthnewsofalabama.com/article/912532964-nha-s-2026-industry-outlook-highlights-growing-need-for-allied-health-professionals-and-the-rising-value-of-certification Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 NHA’s 2026 Industry Outlook Highlights Growing Need for Allied Health Professionals and the Rising Value of Certification https://ml.globenewswire.com/media/MzAyYWQyYzEtZjgzYS00N2M0LWExZjMtNjI1MjRlNjJmN2YwLTEyMDA5MjYtMjAyNi0wNS0xMy1lbg==/tiny/Ascend-Learning-Inc-.png https://www.healthnewsofalabama.com/article/912533092-lite-strategy-reports-fiscal-2026-third-quarter-results Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Lite Strategy Reports Fiscal 2026 Third Quarter Results https://ml.globenewswire.com/media/d0cc6e77-6ce2-4afa-adb0-13a8e61c35fb/small/lite-strategy-logo-dark-jpg.jpg https://www.healthnewsofalabama.com/article/912533197-real-time-intoxication-detection-platforms-target-expanding-multibillion-dollar-healthcare-opportunities Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://www.healthnewsofalabama.com/article/912533206-next-generation-glp-1-innovation-could-unlock-massive-metabolic-healthcare-market-opportunities Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://www.healthnewsofalabama.com/article/912533210-cns-drug-delivery-technologies-are-reshaping-alzheimer-s-and-biodefense-research Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://www.healthnewsofalabama.com/article/912533296-srx-health-solutions-invests-in-astro-investment-xvii-an-affiliate-of-astro-capital-and-spv-with-investments-in-spacex-and-other-artificial Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies https://ml.globenewswire.com/media/768807fe-a29b-48f5-be44-977c8eaf49f0/small/srxlogo-jpg.jpg https://www.healthnewsofalabama.com/article/912533307-intelligent-bio-solutions-reports-fiscal-third-quarter-revenue-growth-of-46-year-over-year Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year https://ml.globenewswire.com/media/d4eaef42-9420-48b7-8019-0285720d678c/small/ibs-primary-logo-blue-png.png https://www.healthnewsofalabama.com/article/912533320-vor-bio-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health News of Alabama en PressRelease 2026-05-13T12:30:00+00:00 Vor Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://www.healthnewsofalabama.com/article/912508626-candel-therapeutics-to-present-at-upcoming-investor-conferences Health News of Alabama en PressRelease 2026-05-13T12:05:00+00:00 Candel Therapeutics to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.healthnewsofalabama.com/article/912508575-silexion-therapeutics-announces-initiation-of-gmp-clinical-supply-manufacturing-of-sil204-with-leading-global-cdmo-and-new-approval-of-phase-2-3 Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center https://ml-eu.globenewswire.com/media/1070dc42-db79-4712-af48-38ffbdf3b140/small/screenshot-2025-05-13-at-15-29-06-png.png https://www.healthnewsofalabama.com/article/912508631-valitor-to-participate-in-the-2026-rbc-capital-markets-global-healthcare-conference Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Valitor to Participate in the 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png https://www.healthnewsofalabama.com/article/912508652-sionna-therapeutics-to-participate-in-the-2026-rbc-capital-markets-global-healthcare-conference Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png https://www.healthnewsofalabama.com/article/912508690-dr-jonathan-gavras-joins-healthmap-solutions-as-chief-medical-officer Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Dr. Jonathan Gavras Joins Healthmap Solutions as Chief Medical Officer https://ml.globenewswire.com/media/8b459708-4818-4fa6-ba35-291cf26bbee7/small/healthmap-150x-90-1200-jpg.jpg https://www.healthnewsofalabama.com/article/912508695-century-therapeutics-reports-first-quarter-financial-results-and-business-updates Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Century Therapeutics Reports First Quarter Financial Results and Business Updates  https://ml.globenewswire.com/media/0c4efad5-3786-4f61-b572-f2b723ecedaa/small/century-primarylogo-pfade-rgb-rz-png.png https://www.healthnewsofalabama.com/article/912508732-verrica-pharmaceuticals-to-participate-in-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912508743-oryzon-to-present-updated-positive-clinical-data-for-iadademstat-in-acute-myeloid-leukemia-at-eha-2026 Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026 https://ml.globenewswire.com/media/56e13ce4-e7d9-45ee-85e9-26feec9b7c6f/small/logo-png.png https://www.healthnewsofalabama.com/article/912508765-electrocore-announces-publication-in-jama-highlighting-the-benefits-of-adding-quell-electrical-nerve-stimulation-to-outpatient-physical-therapy-in Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://www.healthnewsofalabama.com/article/912508834-pacira-biosciences-to-participate-in-fireside-chats-at-three-upcoming-healthcare-conferences Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.healthnewsofalabama.com/article/912508917-inmune-bio-named-founding-member-of-the-american-biotech-innovation-alliance-abia-as-u-s-biotech-sector-navigates-strategic-inflection-point Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://www.healthnewsofalabama.com/article/912508938-zusduri-median-duration-of-response-still-not-reached-with-64-5-36-month-duration-of-response-in-the-pivotal-envision-trial Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial https://ml.globenewswire.com/media/8b4e2813-5822-438f-a0d8-1a2c99628858/small/urogen-logo2-r-002-png.png https://www.healthnewsofalabama.com/article/912508996-calidi-biotherapeutics-confirms-featured-speaker-presentation-tomorrow-at-the-asgct-conference-in-boston Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.healthnewsofalabama.com/article/912509006-protara-therapeutics-announces-first-quarter-2026-financial-results-and-provides-a-business-update Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update https://ml.globenewswire.com/media/ba98d7ed-6917-452d-a864-6f60caa53c1b/small/protara-therapeutics-2x-png.png https://www.healthnewsofalabama.com/article/912509031-moleculin-announces-imminent-miracle-trial-unblinding-as-blinded-data-continue-to-significantly-outperform-historical-benchmarks Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Moleculin Announces Imminent MIRACLE Trial Unblinding as Blinded Data Continue to Significantly Outperform Historical Benchmarks https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.healthnewsofalabama.com/article/912509390-ars-pharmaceuticals-strengthens-leadership-team-with-appointment-of-industry-veteran-donn-casale-as-president Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President https://ml.globenewswire.com/media/8feeb9d1-ed0c-491a-988b-a2b54778e825/small/ars-logo-png.png https://www.healthnewsofalabama.com/article/912509575-sapu-nano-announces-first-patient-dosed-in-phase-1b-trial-of-sapu003-an-intravenous-deciparticle-formulation-of-everolimus Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus https://ml.globenewswire.com/media/bb58c424-43e8-41dc-bbec-f53dc94cfc28/small/logo-1-jpg.jpg https://www.healthnewsofalabama.com/article/912509579-sapu-nano-sapu003-deciparticle-1b Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Sapu Nano 宣布 Sapu003 (基于 Deciparticle™ 技术的依维莫司静脉注射剂型) 1b 期临床试验完成首例患者给药 https://ml.globenewswire.com/media/bb58c424-43e8-41dc-bbec-f53dc94cfc28/small/ https://www.healthnewsofalabama.com/article/912509587-sapu-nano-deciparticle-sapu003-1b Health News of Alabama en PressRelease 2026-05-13T12:00:00+00:00 Sapu Nano 宣佈旗下靜脈注射 Deciparticle™ 配方依維莫司 —— Sapu003 的 1b 期試驗，已為首位患者完成給藥 https://ml.globenewswire.com/media/bb58c424-43e8-41dc-bbec-f53dc94cfc28/small/ https://www.healthnewsofalabama.com/article/912509802-innocare-announce-first-subject-dosed-in-phase-1-clinical-trial-of-icp-054-a-novel-potentially-best-in-class-oral-il-17aa-af-inhibitor Health News of Alabama en PressRelease 2026-05-13T11:43:28+00:00 InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://www.healthnewsofalabama.com/article/912508675-brainsway-reports-first-quarter-2026-financial-results-and-operational-highlights Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights https://ml.globenewswire.com/media/ea01c8f7-39be-46d2-a8e0-bc05994f170e/small/brainsway-2021-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912508891-arbutus-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg https://www.healthnewsofalabama.com/article/912508895-dyne-therapeutics-to-participate-in-upcoming-investor-conferences Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 Dyne Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/2aa597a4-9b5c-4f0c-9ada-c5e06fa7d4de/small/dynelogo-r-final-full-color-rgb-jpg.jpg https://www.healthnewsofalabama.com/article/912508944-pyxis-oncology-to-participate-in-upcoming-investor-conferences Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 Pyxis Oncology to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912508950-abeona-therapeutics-reports-first-quarter-2026-results-and-provides-pipeline-update Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update https://ml.globenewswire.com/media/f11f9f14-9744-4666-aef3-9771488c41bd/small/thumb-1740-12-silhouette-vertical-full-color-png.png https://www.healthnewsofalabama.com/article/912508961-palvella-therapeutics-announces-uplisting-to-the-nasdaq-global-market Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.healthnewsofalabama.com/article/912508970-briacell-adds-penn-medicine-s-abramson-cancer-center-as-clinical-site-in-pivotal-phase-3-breast-cancer-study Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study https://ml.globenewswire.com/media/88b9408d-31d4-4afd-beff-f855719a15d8/small/briacell-logo-square-a-jpg.jpg https://www.healthnewsofalabama.com/article/912508990-altimmune-announces-first-quarter-2026-financial-results-and-business-update Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 Altimmune Announces First Quarter 2026 Financial Results and Business Update https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://www.healthnewsofalabama.com/article/912509177-hengrui-pharma-and-kailera-therapeutics-announce-clinical-data-presentations-at-the-american-diabetes-association-86th-scientific-sessions Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions https://ml.globenewswire.com/media/c0b33a3d-0c2b-45b0-ace8-6ff585b41339/small/kailera-logo-png.png https://www.healthnewsofalabama.com/article/912509207-medipharm-labs-reports-first-quarter-2026-results-achieving-positive-adjusted-ebitda Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA https://ml.globenewswire.com/media/7a534238-60aa-4187-979d-8f4d83fa58c1/small/medipharm-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912509519-polypid-provides-corporate-update-and-reports-first-quarter-2026-financial-results Health News of Alabama en PressRelease 2026-05-13T11:30:00+00:00 PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/202fc254-aac1-49c2-a08d-cc0efc938460/small/polypid-logo-final-rgb-2x-100-jpg.jpg https://www.healthnewsofalabama.com/article/912509266-kane-biotech-presents-data-to-global-wound-care-community-at-wcet-nswocc-2026-joint-congress Health News of Alabama en PressRelease 2026-05-13T11:25:00+00:00 Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress https://ml.globenewswire.com/media/151431c7-16a7-45ce-b235-2e7b037c555a/medium/fda-cleared-and-health-canada-approved-revyve-antimicrobial.jpg https://www.healthnewsofalabama.com/article/912509066-altimmune-to-present-results-of-pemvidutide-in-mash-in-an-oral-presentation-and-multiple-poster-presentations-at-easl-congress-2026 Health News of Alabama en PressRelease 2026-05-13T11:15:00+00:00 Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026 https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://www.healthnewsofalabama.com/article/912509644-milestone-pharmaceuticals-announces-first-quarter-2026-financial-results-and-provides-corporate-update Health News of Alabama en PressRelease 2026-05-13T11:11:06+00:00 Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png https://www.healthnewsofalabama.com/article/912508965-ocugen-to-participate-in-upcoming-may-scientific-and-investor-conferences Health News of Alabama en PressRelease 2026-05-13T11:02:00+00:00 Ocugen to Participate in Upcoming May Scientific and Investor Conferences https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://www.healthnewsofalabama.com/article/912508651-opus-genetics-to-present-at-the-rbc-capital-markets-2026-global-healthcare-conference Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://www.healthnewsofalabama.com/article/912508724-pds-biotech-reports-first-quarter-2026-financial-results-and-provides-clinical-programs-and-corporate-update Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update https://ml.globenewswire.com/media/e2e7d124-dbd4-4140-9cc5-449d3488a902/small/pds-biotech-logo-png.png https://www.healthnewsofalabama.com/article/912508742-atea-pharmaceuticals-to-present-three-abstracts-at-easl-2026-congress-highlighting-progress-across-viral-hepatitis-pipeline Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png https://www.healthnewsofalabama.com/article/912508804-avalo-therapeutics-reports-first-quarter-2026-financial-results-and-recent-business-updates Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://www.healthnewsofalabama.com/article/912508907-corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912508939-nurix-therapeutics-to-participate-in-upcoming-investor-conferences Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Nurix Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/65f50366-0a4e-4329-b0f5-f737c6145524/small/new-primary-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912508980-humacyte-announces-first-quarter-2026-financial-results-and-provides-business-update Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://www.healthnewsofalabama.com/article/912509158-verano-submits-dea-registration-applications-for-state-licensed-medical-cannabis-businesses-following-landmark-federal-rescheduling-order Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order  https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png https://www.healthnewsofalabama.com/article/912509163-biocryst-to-present-new-real-world-evidence-underscoring-the-ongoing-burden-of-pediatric-hereditary-angioedema-at-ispor-2026 Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026 https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.healthnewsofalabama.com/article/912509292-beyondspring-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/409b2d1e-aaff-4be0-8a1a-b28e12ced378/small/beyondspring-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912509297-upstream-bio-reports-first-quarter-2026-financial-results-and-recent-business-highlights Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/f1393297-d0b6-4706-960f-6128bcd0c6a4/small/upstream-logo-rgb-300x300px-jpg.jpg https://www.healthnewsofalabama.com/article/912509301-seer-files-patent-infringement-lawsuit-against-nanomics Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Seer Files Patent Infringement Lawsuit Against Nanomics https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://www.healthnewsofalabama.com/article/912509312-sagimet-biosciences-to-participate-in-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.healthnewsofalabama.com/article/912509600-following-positive-phase-2a-pancreatic-cancer-data-can-fite-advances-namodenoson-into-phase-2b-combination-study-with-immunotherapy Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy https://ml.globenewswire.com/media/ca5e71b0-5c40-4d54-96ce-7ce704201c96/small/can-fite-biopharma-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912509608-andera-partners-leads-20-million-series-d-financing-in-rivermark-medical Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Andera Partners Leads $20 Million Series D Financing in Rivermark Medical https://ml.globenewswire.com/media/84827000-8d17-4bc9-9829-3a4706db49ea/small/andera-logo-rvb-png.png https://www.healthnewsofalabama.com/article/912509617-kamada-reports-first-quarter-2026-financial-results-and-affirms-2026-annual-guidance-expecting-significantly-stronger-remainder-of-the-year Health News of Alabama en PressRelease 2026-05-13T11:00:00+00:00 Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year https://ml.globenewswire.com/media/6334b598-e958-4ac2-b196-aac2c24ea458/small/picture1-jpg.jpg https://www.healthnewsofalabama.com/article/912509105-zenas-biopharma-announces-first-subject-dosed-in-phase-1-clinical-trial-of-zb021-a-novel-potentially-best-in-class-oral-il-17aa-af-inhibitor Health News of Alabama en PressRelease 2026-05-13T10:50:00+00:00 Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912508708-veru-reports-fiscal-2026-second-quarter-financial-results-and-phase-2b-plateau-clinical-trial-progress Health News of Alabama en PressRelease 2026-05-13T10:30:00+00:00 Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress https://ml.globenewswire.com/media/9c96f1a7-e104-47d4-8011-8c19496681c2/small/final-veruinclogo-rgb-300dpi-jpg.jpg https://www.healthnewsofalabama.com/article/912508714-aprea-therapeutics-reports-first-quarter-2026-financial-results-and-provides-a-corporate-update Health News of Alabama en PressRelease 2026-05-13T10:30:00+00:00 Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912483877-voyager-asgct-late-breaker-single-iv-dose-of-vy1706-well-tolerated-reduced-tau-in-3-month-glp-toxicology-data-clinical-trial-in-alzheimer-s-disease Health News of Alabama en PressRelease 2026-05-13T10:01:00+00:00 Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026 https://ml.globenewswire.com/media/f775f55a-83dd-4b38-bf92-bb9b588522bd/small/voyager-logos-square-logo-light-png.png https://www.healthnewsofalabama.com/article/912483853-zymeworks-announces-participation-in-upcoming-investor-conferences Health News of Alabama en PressRelease 2026-05-13T10:00:00+00:00 Zymeworks Announces Participation in Upcoming Investor Conferences https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png https://www.healthnewsofalabama.com/article/912483898-zenas-biopharma-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health News of Alabama en PressRelease 2026-05-13T10:00:00+00:00 Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912484040-nvision-expands-from-quantum-sensing-to-quantum-computing-to-accelerate-discovery-and-validation-of-new-therapies Health News of Alabama en PressRelease 2026-05-13T10:00:00+00:00 NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies https://ml.globenewswire.com/media/2637f0c5-a255-4bdd-8508-1eae03c83c7d/medium/organic-molecular-crystal-containing-qubit-molecules-on-a-sa.jpg https://www.healthnewsofalabama.com/article/912483773-heparegenix-to-present-interim-phase-1b-data-for-darizmetinib-hrx215-in-a-late-breaking-oral-presentation-at-the-european-association-for-the-study Health News of Alabama en PressRelease 2026-05-13T09:00:00+00:00 HepaRegeniX to Present Interim Phase 1b Data for Darizmetinib (HRX215) in a Late-Breaking Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2026 https://ml-eu.globenewswire.com/media/13819f7b-65d3-4e76-bb03-104b2a3dbb0d/small/heparegenix-logo-png.png https://www.healthnewsofalabama.com/article/912464327-new-anglia-university-highlights-growing-demand-for-international-medical-education-among-british-students Health News of Alabama en PressRelease 2026-05-13T08:06:00+00:00 New Anglia University Highlights Growing Demand for International Medical Education Among British Students https://ml.globenewswire.com/media/c4a7a0f2-fc15-40c2-902d-372e5ca0c74d/small/image-1-png.png https://www.healthnewsofalabama.com/article/912464739-anaveon-appoints-thomas-p-mathers-as-chair-of-the-board-of-directors Health News of Alabama en PressRelease 2026-05-13T08:00:00+00:00 Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors https://ml.globenewswire.com/media/9898afec-1c88-4bf2-9791-582f5321195b/medium/thomas-p-mathers.jpg https://www.healthnewsofalabama.com/article/912464291-inventiva-to-present-abstracts-at-the-easl-congress-2026 Health News of Alabama en PressRelease 2026-05-13T06:30:00+00:00 Inventiva to Present Abstracts at the EASL Congress 2026 https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/logo-iva-jpg.jpg https://www.healthnewsofalabama.com/article/912464296-inventiva-pr-sentera-plusieurs-abstracts-lors-de-l-easl-congress-2026 Health News of Alabama en PressRelease 2026-05-13T06:30:00+00:00 Inventiva présentera plusieurs abstracts lors de l’EASL Congress 2026 https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/ https://www.healthnewsofalabama.com/article/912464757-fortis-life-sciences-vergibt-den-abnano-vhh-discovery-grant-2026-an-deliver-biosciences-im-bereich-der-gezielten-wirkstoffabgabe Health News of Alabama en PressRelease 2026-05-13T06:20:00+00:00 Fortis Life Sciences vergibt den AbNano® VHH Discovery Grant 2026 an Deliver Biosciences im Bereich der gezielten Wirkstoffabgabe https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://www.healthnewsofalabama.com/article/912464760-fortis-life-sciences-attribue-la-subvention-la-d-couverte-abnano-vhh-discovery-2026-deliver-biosciences-pour-la-recherche-sur-l-administration Health News of Alabama en PressRelease 2026-05-13T06:20:00+00:00 Fortis Life Sciences attribue la subvention à la découverte AbNano® VHH Discovery 2026 à Deliver Biosciences pour la recherche sur l’administration ciblée de médicaments https://ml.globenewswire.com/media/35b82fbc-92f2-41d4-abbb-3a83618a33b7/small/fortis-logo-purple-png.png https://www.healthnewsofalabama.com/article/912446091-aligos-therapeutics-announces-ten-abstracts-accepted-for-presentation-at-the-easl-congress-2026 Health News of Alabama en PressRelease 2026-05-13T06:05:00+00:00 Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026 https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png https://www.healthnewsofalabama.com/article/912446099-fangzhou-showcases-ai-h2h-chronic-disease-service-innovations-at-the-national-intelligent-medicine-conference Health News of Alabama en PressRelease 2026-05-13T06:03:39+00:00 Fangzhou Showcases “AI+H2H” Chronic Disease Service Innovations at the National Intelligent Medicine Conference https://ml.globenewswire.com/media/294c081f-a526-49c8-925a-1e407972f343/small/logo-compressed-png.png https://www.healthnewsofalabama.com/article/912446095-assembly-biosciences-to-present-topline-phase-1a-data-on-hepatitis-delta-virus-entry-inhibitor-abi-6250-at-the-easl-congress-2026 Health News of Alabama en PressRelease 2026-05-13T06:00:00+00:00 Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026 https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png https://www.healthnewsofalabama.com/article/912446020-valneva-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Health News of Alabama en PressRelease 2026-05-13T05:00:00+00:00 Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/val-logo-4c-jpg.jpg https://www.healthnewsofalabama.com/article/912446031-valneva-publie-ses-r-sultats-financiers-audit-s-et-consolid-s-pour-le-premier-trimestre-2026 Health News of Alabama en PressRelease 2026-05-13T05:00:00+00:00 Valneva publie ses résultats financiers audités et consolidés pour le premier trimestre 2026 https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/ https://www.healthnewsofalabama.com/article/912423759-ascentage-pharma-to-present-17-clinical-advances-at-2026-european-hematology-association-congress Health News of Alabama en PressRelease 2026-05-13T02:15:00+00:00 Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress https://ml.globenewswire.com/media/b9623a51-a13b-4b80-8152-61d5014f4a0a/small/2025-11-12-ascentage-600x600-png.png https://www.healthnewsofalabama.com/article/912376339-visiocore-under-investigation-the-advanced-eyesight-vision-support-capsules-with-organic-ingredients Health News of Alabama en PressRelease 2026-05-13T00:02:06+00:00 VisioCore Under Investigation: The Advanced Eyesight Vision Support Capsules with Organic Ingredients https://zingfast.com/wp-content/uploads/2026/05/VisioCore-Advanced-Eyesight-Vision-Support-Capsules-with-Organic-Ingredients.jpg https://www.healthnewsofalabama.com/article/912376332-visi-flora-under-investigation-the-leading-gut-eye-vitamins-formulation-on-the-market-for-sharp-vision-support-by-visiflora Health News of Alabama en PressRelease 2026-05-13T00:01:55+00:00 Visi Flora Under Investigation: The Leading Gut-Eye Vitamins Formulation on the Market for Sharp Vision Support by VisiFlora https://zingfast.com/wp-content/uploads/2026/05/Visi-Flora.png https://www.healthnewsofalabama.com/article/912376288-anteris-announces-results-for-the-first-quarter-of-2026 Health News of Alabama en PressRelease 2026-05-12T23:00:00+00:00 Anteris Announces Results for the First Quarter of 2026 https://ml.globenewswire.com/media/90a5ae8d-7cf0-4a3d-b38c-f4ad7e3fbf0e/small/anteris-tech-rgb-blue-png.png https://www.healthnewsofalabama.com/article/912376281-bluesight-launches-prism-an-ai-platform-built-for-health-systems-debuting-with-prism-assistant Health News of Alabama en PressRelease 2026-05-12T22:43:53+00:00 Bluesight Launches Prism, an AI Platform Built for Health Systems, Debuting with Prism Assistant https://ml.globenewswire.com/media/6889b03a-b86b-4608-8163-251c0ac07bbf/medium/cover-image.jpg https://www.healthnewsofalabama.com/article/912351771-cosciens-biopharma-inc-reports-q1-2026-results Health News of Alabama en PressRelease 2026-05-12T21:05:00+00:00 COSCIENS Biopharma Inc. Reports Q1 2026 Results https://ml.globenewswire.com/media/703faafa-78e2-4d67-be2a-457eb4f57340/small/picture2-png.png https://www.healthnewsofalabama.com/article/912351774-bbot-reports-first-quarter-2026-financial-results-and-update-on-corporate-progress Health News of Alabama en PressRelease 2026-05-12T21:03:31+00:00 BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.healthnewsofalabama.com/article/912350660-sanuwave-announces-revenues-and-financial-results-for-q1-fy2026 Health News of Alabama en PressRelease 2026-05-12T21:00:00+00:00 Sanuwave Announces Revenues and Financial Results for Q1 FY2026 https://ml.globenewswire.com/media/6e709528-90af-4ff5-a08a-c0ea5a2cd4ab/small/sanuwave-logo-002-png.png https://www.healthnewsofalabama.com/article/912351557-eupraxia-pharmaceuticals-reports-first-quarter-2026-financial-results Health News of Alabama en PressRelease 2026-05-12T21:00:00+00:00 Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.healthnewsofalabama.com/article/912350513-dbv-technologies-to-participate-in-the-h-c-wainwright-4th-annual-bioconnect-investor-conference-at-nasdaq Health News of Alabama en PressRelease 2026-05-12T20:30:00+00:00 DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/logo1-jpg.jpg https://www.healthnewsofalabama.com/article/912350534-dbv-technologies-participera-la-4e-dition-de-la-conf-rence-annuelle-bioconnect-investor-organis-e-par-h-c-wainwright-au-nasdaq Health News of Alabama en PressRelease 2026-05-12T20:30:00+00:00 DBV Technologies participera à la 4e édition de la conférence annuelle BioConnect Investor organisée par H.C. Wainwright au Nasdaq https://ml-eu.globenewswire.com/media/274bd0ae-19c4-4821-85ce-7fe85ee610b5/small/ https://www.healthnewsofalabama.com/article/912350602-innovage-appoints-jennifer-browne-as-president-and-chief-operating-officer Health News of Alabama en PressRelease 2026-05-12T20:30:00+00:00 InnovAge Appoints Jennifer Browne as President and Chief Operating Officer https://ml.globenewswire.com/media/a1b976fe-053f-43be-b43c-532393a7f314/small/inn-logotag-rgb-jpg.jpg https://www.healthnewsofalabama.com/article/912350606-eton-pharmaceuticals-to-participate-in-upcoming-investor-conferences Health News of Alabama en PressRelease 2026-05-12T20:30:00+00:00 Eton Pharmaceuticals to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/db07cafa-b35c-4d61-a1a1-d330caf67ad2/small/eton-logo-png.png https://www.healthnewsofalabama.com/article/912350974-tonix-pharmaceuticals-to-participate-in-two-investor-conferences-in-may Health News of Alabama en PressRelease 2026-05-12T20:30:00+00:00 Tonix Pharmaceuticals to Participate in Two Investor Conferences in May https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.healthnewsofalabama.com/article/912351067-alignment-healthcare-strengthens-leadership-team-to-support-long-term-growth-and-shareholder-value-creation Health News of Alabama en PressRelease 2026-05-12T20:30:00+00:00 Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation https://ml.globenewswire.com/media/c6122501-032d-4425-bb0d-759ee3d3fe68/small/alignmenthealthcare-primary-logo-verticala-png.png https://www.healthnewsofalabama.com/article/912351138-crescent-biopharma-announces-grants-of-inducement-awards Health News of Alabama en PressRelease 2026-05-12T20:30:00+00:00 Crescent Biopharma Announces Grants of Inducement Awards https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://www.healthnewsofalabama.com/article/912327817-orchestra-biomed-reports-first-quarter-2026-financial-results-and-highlights-recent-business-updates Health News of Alabama en PressRelease 2026-05-12T20:18:12+00:00 Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.healthnewsofalabama.com/article/912350573-palisade-bio-reports-first-quarter-2026-financial-results-and-highlights-continued-clinical-progress-of-pali-2108 Health News of Alabama en PressRelease 2026-05-12T20:15:00+00:00 Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108 https://ml.globenewswire.com/media/0beaede8-1c7c-4f77-84a7-b1efd54c343c/small/logo-png.png https://www.healthnewsofalabama.com/article/912351026-anaptys-announces-first-quarter-2026-financial-results-and-provides-business-update Health News of Alabama en PressRelease 2026-05-12T20:15:00+00:00 Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/eb223f66-e7e0-4e0a-94e7-a3f7a06b13ab/small/anaptys-logo-png.png https://www.healthnewsofalabama.com/article/912351155-spectral-ai-announces-2026-first-quarter-financial-results Health News of Alabama en PressRelease 2026-05-12T20:10:00+00:00 Spectral AI Announces 2026 First Quarter Financial Results https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912351195-solid-biosciences-reports-first-quarter-2026-financial-results-and-provides-business-updates Health News of Alabama en PressRelease 2026-05-12T20:08:21+00:00 Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://www.healthnewsofalabama.com/article/912351177-interpace-biosciences-announces-first-quarter-2026-financial-and-business-results Health News of Alabama en PressRelease 2026-05-12T20:06:19+00:00 Interpace Biosciences Announces First Quarter 2026 Financial and Business Results https://ml.globenewswire.com/media/b8fe939f-066b-4977-83f6-13d975b7c4e7/small/interpacebiosciences-new-logo-png.png https://www.healthnewsofalabama.com/article/912350683-stereotaxis-reports-2026-first-quarter-financial-results-business-updates Health News of Alabama en PressRelease 2026-05-12T20:06:00+00:00 Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png https://www.healthnewsofalabama.com/article/912327091-nyxoah-reports-first-quarter-2026-financial-and-operating-results Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Nyxoah Reports First Quarter 2026 Financial and Operating Results https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png https://www.healthnewsofalabama.com/article/912327126-nyxoah-publie-ses-r-sultats-financiers-et-op-rationnels-du-premier-trimestre-2026 Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Nyxoah Publie ses Résultats Financiers et Opérationnels du Premier Trimestre 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/ https://www.healthnewsofalabama.com/article/912327130-lb-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/90903161-520e-409f-b2ac-dd18677b4bb8/small/lb-pharma-logo-png.png https://www.healthnewsofalabama.com/article/912327153-connect-biopharma-to-present-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference https://ml.globenewswire.com/media/831dcc2a-691d-4cad-813e-855f9fa2bd69/small/connect-logo-cmyk-jpg.jpg https://www.healthnewsofalabama.com/article/912327182-bolt-biotherapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/fb5e6ce9-fbe4-4a9b-a822-dac88f68c979/small/bolt-logo-png.png https://www.healthnewsofalabama.com/article/912327192-nurix-therapeutics-announces-bexobrutideg-oral-presentation-at-the-2026-european-hematology-association-congress Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress https://ml.globenewswire.com/media/65f50366-0a4e-4329-b0f5-f737c6145524/small/new-primary-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912327197-surrozen-to-present-at-upcoming-healthcare-investor-conference Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Surrozen to Present at Upcoming Healthcare Investor Conference https://ml.globenewswire.com/media/f8766f36-378a-41ad-9256-3cf0ca847440/small/logoonly-png.png https://www.healthnewsofalabama.com/article/912327201-bridgebio-oncology-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.healthnewsofalabama.com/article/912327210-neumora-therapeutics-to-participate-in-2026-rbc-capital-markets-global-healthcare-conference Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912327213-fractyl-health-reports-first-quarter-2026-financial-results-and-business-updates Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates https://ml.globenewswire.com/media/3a379315-9c07-4655-883e-7e7f26c67778/small/fractyl-logo-png.png https://www.healthnewsofalabama.com/article/912327283-pharvaris-reports-first-quarter-2026-financial-results-and-provides-business-update Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.healthnewsofalabama.com/article/912327299-rezolute-reports-third-quarter-fiscal-2026-financial-results-and-provides-business-update Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/bbe03de3-6870-4230-b875-d8965a3d1b97/small/rezolute-jpg.jpg https://www.healthnewsofalabama.com/article/912327333-atea-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png https://www.healthnewsofalabama.com/article/912327349-zentalis-pharmaceuticals-reports-first-quarter-2026-financial-results-and-clinical-progress Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress https://ml.globenewswire.com/media/ecb98bea-7a9f-4319-874c-1911777a5a46/small/zentalis-logo-full-color-png.png https://www.healthnewsofalabama.com/article/912327370-sellas-life-sciences-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/4ff07596-ddcc-4df5-be2f-e31a35217739/small/sellas-logo-png.png https://www.healthnewsofalabama.com/article/912327406-biostem-technologies-to-present-at-the-16th-annual-ld-micro-invitational Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 BioStem Technologies to Present at the 16th Annual LD Micro Invitational https://ml.globenewswire.com/media/da0ea21a-fd6e-425a-a8f2-6f69dc2b4612/small/biostem-main-logo-png.png https://www.healthnewsofalabama.com/article/912327423-rani-therapeutics-to-participate-in-the-h-c-wainwright-annual-bioconnect-investor-conference Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference https://ml.globenewswire.com/media/8ce7774c-3696-4aa1-8bcd-413805f0a642/small/rani-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912327427-jushi-holdings-inc-reports-first-quarter-2026-financial-results Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Jushi Holdings Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/e65f15fd-322c-4847-83c5-ceafe27f97d5/small/jushi-png.png https://www.healthnewsofalabama.com/article/912327440-gyre-therapeutics-announces-nmpa-acceptance-of-new-drug-application-for-f351-hydronidone-for-chb-induced-liver-fibrosis-treatment Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment https://ml.globenewswire.com/media/24951768-57e9-4d7a-b969-f00258b17136/small/gyre-logo-png.png https://www.healthnewsofalabama.com/article/912327446-relmada-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/8a986b0a-11c8-4551-b0ad-ec20fe2fe40a/small/relmada-logo-png.png https://www.healthnewsofalabama.com/article/912327452-damora-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-highlights Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights https://ml.globenewswire.com/media/547722cf-495b-4464-97a9-35bea3fa5d15/small/damora-rgb-png.png https://www.healthnewsofalabama.com/article/912327461-tela-bio-reports-first-quarter-2026-financial-results Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 TELA Bio Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/62aad9be-813a-415e-990b-f27442cbec50/small/download-png.png https://www.healthnewsofalabama.com/article/912327474-maxcyte-reports-first-quarter-2026-financial-results-and-reiterates-full-year-2026-guidance Health News of Alabama en PressRelease 2026-05-12T20:05:00+00:00 MaxCyte Reports First Quarter 2026 Financial Results and Reiterates Full Year 2026 Guidance https://ml.globenewswire.com/media/8f0f0d48-fc4f-4d03-ac70-f4d096a780bd/small/maxcyte-logo-600x600-png.png https://www.healthnewsofalabama.com/article/912327359-kyverna-therapeutics-announces-initiation-of-rolling-sps-bla-submission-and-reports-first-quarter-2026-financial-results Health News of Alabama en PressRelease 2026-05-12T20:02:00+00:00 Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.healthnewsofalabama.com/article/912327431-kura-oncology-reports-first-quarter-2026-financial-results Health News of Alabama en PressRelease 2026-05-12T20:02:00+00:00 Kura Oncology Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.healthnewsofalabama.com/article/912327168-aura-biosciences-to-participate-in-upcoming-investor-conferences Health News of Alabama en PressRelease 2026-05-12T20:01:00+00:00 Aura Biosciences to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.healthnewsofalabama.com/article/912327228-inhibikase-therapeutics-announces-first-quarter-2026-financial-results-and-highlights-recent-activity Health News of Alabama en PressRelease 2026-05-12T20:01:00+00:00 Inhibikase Therapeutics Announces First Quarter 2026 Financial Results and Highlights Recent Activity https://ml.globenewswire.com/media/32b8d8bc-ebf8-43c0-866a-6613b22263b1/small/ikt-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912327364-verrica-pharmaceuticals-reports-first-quarter-2026-financial-results Health News of Alabama en PressRelease 2026-05-12T20:01:00+00:00 Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912327442-pacira-biosciences-sends-letter-to-stockholders-reiterating-superior-qualifications-of-its-board-nominees Health News of Alabama en PressRelease 2026-05-12T20:01:00+00:00 Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.healthnewsofalabama.com/article/912327638-nkarta-reports-first-quarter-2026-financial-results-and-corporate-highlights Health News of Alabama en PressRelease 2026-05-12T20:01:00+00:00 Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/09e7df7f-9555-45c9-bef1-86131c859ed3/small/nkarta-logo-2022-jpg.jpg https://www.healthnewsofalabama.com/article/912327713-maze-therapeutics-reports-first-quarter-2026-financial-results-and-recent-highlights Health News of Alabama en PressRelease 2026-05-12T20:01:00+00:00 Maze Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights https://ml.globenewswire.com/media/20759f53-8fbe-4af8-9fc1-3a4a4ac5c195/small/lol-png.png https://www.healthnewsofalabama.com/article/912327456-cytokinetics-to-participate-in-the-2026-rbc-capital-markets-global-healthcare-conference Health News of Alabama en PressRelease 2026-05-12T20:00:00+00:00 Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.healthnewsofalabama.com/article/912304549-the-25th-tunnel-to-towers-nyc-5k-run-walk-is-set-for-september-27th Health News of Alabama en PressRelease 2026-05-12T17:58:10+00:00 The 25th Tunnel to Towers NYC 5K Run & Walk is Set for September 27th https://ml.globenewswire.com/media/NDYwYWU5NTAtODg3Yi00MzQ5LTllZDktMGQzODc5YTQ3YjUwLTExMzQ0NDMtMjAyNi0wNS0xMi1lbg==/tiny/Stephen-Siller-Tunnel-To-Tower.png https://www.healthnewsofalabama.com/article/912304451-update-skye-bioscience-reports-first-quarter-2026-financial-results-and-business-update Health News of Alabama en PressRelease 2026-05-12T17:33:53+00:00 UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update https://ml.globenewswire.com/media/905e06d8-af43-4f7a-b097-8c12ce1d3aa0/small/skye-darkblue-jpg.jpg https://www.healthnewsofalabama.com/article/912282903-recordati-strong-momentum-of-the-group-continues-into-the-first-quarter-of-2026-net-revenue-4-9-ebitda-1-5-0-adjusted-net-income-2-7-2 Health News of Alabama en PressRelease 2026-05-12T16:46:39+00:00 RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2% https://ml-eu.globenewswire.com/media/a64917fc-da51-47f4-a36a-dc04b029ed8b/small/r-logo2023-rgb-3-png.png https://www.healthnewsofalabama.com/article/912282909-recordati-il-forte-slancio-del-gruppo-prosegue-nel-primo-trimestre-del-2026-ricavi-netti-4-9-ebitda-1-5-0-utile-netto-rettificato-2-7-2 Health News of Alabama en PressRelease 2026-05-12T16:46:39+00:00 RECORDATI: IL FORTE SLANCIO DEL GRUPPO PROSEGUE NEL PRIMO TRIMESTRE DEL 2026 RICAVI NETTI +4,9%, EBITDA(1) +5,0%, UTILE NETTO RETTIFICATO(2) +7,2% https://ml-eu.globenewswire.com/media/e91474c3-cf48-41ba-ba26-b56e8278779f/small/r-logo2023-rgb-3-png.png https://www.healthnewsofalabama.com/article/912283056-to-your-health-launches-innovative-online-protein-intake-calculator Health News of Alabama en PressRelease 2026-05-12T16:42:00+00:00 To Your Health Launches Innovative Online Protein Intake Calculator https://ml.globenewswire.com/media/08b8a73d-cd8f-4090-9c45-b598e5c48df4/small/to-your-health-logo.png https://www.healthnewsofalabama.com/article/912283060-atum-s-new-lock-in-platform-solves-bispecific-mispairing Health News of Alabama en PressRelease 2026-05-12T16:37:00+00:00 ATUM’s New Lock-In Platform Solves Bispecific Mispairing https://ml.globenewswire.com/media/874d4e0a-920f-43ea-b167-d50dc78bc154/small/atum-logo.png https://www.healthnewsofalabama.com/article/912283027-sacramento-kings-and-sutter-health-announce-strategic-partnership Health News of Alabama en PressRelease 2026-05-12T16:30:00+00:00 Sacramento Kings and Sutter Health Announce Strategic Partnership https://ml.globenewswire.com/media/MWIwNDMwZmMtODk1OS00MDdhLTk3NmYtOTYzMDM4NmEyM2JlLTUwMDE1MDYxNS0yMDI2LTA1LTEyLWVu/tiny/Sutter-Health.png https://www.healthnewsofalabama.com/article/912282882-high-diet-surpasses-1-700-customer-reviews-as-users-praise-personalized-high-protein-meal-plans Health News of Alabama en PressRelease 2026-05-12T16:09:57+00:00 High Diet Surpasses 1,700 Customer Reviews as Users Praise Personalized High-Protein Meal Plans https://ml-eu.globenewswire.com/media/8189e2bb-1b29-42e3-8d37-b550802925ee/medium/high-diet.png https://www.healthnewsofalabama.com/article/912283071-tevogen-announces-3-million-private-investment-at-8-per-share-a-14-premium-from-latest-market-close Health News of Alabama en PressRelease 2026-05-12T15:45:00+00:00 Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close https://ml.globenewswire.com/media/679fef4d-f32f-46a2-9452-c31af5cf4597/small/tevogen-logo-newswire-png.png https://www.healthnewsofalabama.com/article/912263202-american-urological-association-releases-advanced-prostate-cancer-guideline-amendment Health News of Alabama en PressRelease 2026-05-12T14:55:21+00:00 American Urological Association Releases Advanced Prostate Cancer Guideline Amendment https://ml.globenewswire.com/media/N2FjMTc1MjQtMGNjMS00MjYyLWFjMWEtNjliYjViOTAwNDI1LTEyNzYxOTAtMjAyNi0wNS0xMi1lbg==/tiny/American-Urological-Associatio.png https://www.healthnewsofalabama.com/article/912263125-syndax-highlights-12-revuforj-revumenib-abstracts-accepted-for-eha-2026-advancing-leadership-in-menin-inhibition Health News of Alabama en PressRelease 2026-05-12T14:31:49+00:00 Syndax Highlights 12 Revuforj® (revumenib) Abstracts Accepted for EHA 2026, Advancing Leadership in Menin Inhibition https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912262512-global-urinalysis-market-set-to-reach-usd-6-81-billion-by-2029-marketsandmarkets Health News of Alabama en PressRelease 2026-05-12T14:30:00+00:00 Global Urinalysis Market Set to Reach USD 6.81 Billion by 2029 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.healthnewsofalabama.com/article/912263115-nexgel-to-report-first-quarter-2026-financial-results-on-may-15th Health News of Alabama en PressRelease 2026-05-12T14:27:00+00:00 NEXGEL To Report First Quarter 2026 Financial Results on May 15th https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://www.healthnewsofalabama.com/article/912263057-extendicare-files-business-acquisition-report-in-connection-with-the-cbi-home-health-acquisition Health News of Alabama en PressRelease 2026-05-12T14:06:34+00:00 Extendicare Files Business Acquisition Report in connection with the CBI Home Health Acquisition https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://www.healthnewsofalabama.com/article/912262575-telespecialists-expands-digital-healthcare-access-across-rural-communities-nationwide Health News of Alabama en PressRelease 2026-05-12T14:00:00+00:00 TeleSpecialists Expands Digital Healthcare Access Across Rural Communities Nationwide https://ml.globenewswire.com/media/Nzc2ZWNlNjctOGI3Yi00MTVmLWExYWItOGJlN2E3YmMwMDQ3LTUwMDE0OTY0OS0yMDI2LTA1LTEyLWVu/tiny/TeleSpecialists.png https://www.healthnewsofalabama.com/article/912262649-truveta-and-knit-health-announce-collaboration-to-power-a-new-generation-of-clinical-ai Health News of Alabama en PressRelease 2026-05-12T14:00:00+00:00 Truveta and Knit Health announce collaboration to power a new generation of clinical AI https://ml.globenewswire.com/media/NmQ2OWNjNTYtNTgwMy00YjI0LTlmYWMtZTQzYzkzM2YxMmNmLTEyNzUzNzQtMjAyNi0wNS0xMi1lbg==/tiny/Truveta.png https://www.healthnewsofalabama.com/article/912262678-liveworld-s-new-app-research-council-gives-brands-direct-access-to-frontline-np-and-pa-insights-to-improve-relevance-reach-and-roi Health News of Alabama en PressRelease 2026-05-12T14:00:00+00:00 LiveWorld's New APP Research Council Gives Brands Direct Access to Frontline NP and PA Insights to Improve Relevance, Reach, and ROI https://ml.globenewswire.com/media/b26faeda-6846-4308-830c-e53ab023ba65/small/liveworld-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912263003-mental-health-awareness-month-tpn-health-solves-the-access-crisis-costing-self-insured-stakeholders-health-plans-and-members-the-care-they-deserve Health News of Alabama en PressRelease 2026-05-12T14:00:00+00:00 Mental Health Awareness Month: TPN.health Solves the Access Crisis Costing Self-Insured Stakeholders, Health Plans and Members the Care They Deserve https://ml.globenewswire.com/media/7f287fef-0e9e-4b21-b184-be4db60a5c50/small/tpn-health-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912262589-becker-s-names-leap-distributors-ceo-allen-mason-to-2026-great-leaders-in-healthcare-list Health News of Alabama en PressRelease 2026-05-12T13:47:00+00:00 Becker’s Names Leap Distributors CEO Allen Mason to 2026 Great Leaders in Healthcare List https://ml.globenewswire.com/media/NjA3MGZmNGUtMzA4NS00ZTMwLTlhMzItYjBmN2E4ODQ0ZGY1LTEzMDY0NDctMjAyNi0wNS0xMi1lbg==/tiny/Leap-Distributors.png https://www.healthnewsofalabama.com/article/912262938-kura-oncology-and-kyowa-kirin-to-present-updated-frontline-ziftomenib-7-3-combination-data-at-eha-2026-congress Health News of Alabama en PressRelease 2026-05-12T13:40:16+00:00 Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.healthnewsofalabama.com/article/912245475-aquestive-therapeutics-completes-150-million-debt-refinancing-with-oaktree Health News of Alabama en PressRelease 2026-05-12T13:31:25+00:00 Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree https://ml.globenewswire.com/media/e0b65f93-9565-43d7-a6ff-88b8cbd6adea/small/aquestive-jpg.jpg https://www.healthnewsofalabama.com/article/912244503-agios-submits-snda-to-fda-for-u-s-accelerated-approval-of-mitapivat-in-sickle-cell-disease Health News of Alabama en PressRelease 2026-05-12T13:31:00+00:00 Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://www.healthnewsofalabama.com/article/912245337-first-real-world-evidence-study-of-rytelo-imetelstat-in-lower-risk-myelodysplastic-syndromes-lr-mds-to-be-presented-at-eha-2026 Health News of Alabama en PressRelease 2026-05-12T13:31:00+00:00 First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026  https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.healthnewsofalabama.com/article/912243550-evaxion-to-present-new-data-for-evx-04-an-off-the-shelf-therapeutic-vaccine-for-acute-myeloid-leukemia-at-the-eha-2026-congress Health News of Alabama en PressRelease 2026-05-12T13:30:00+00:00 Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.healthnewsofalabama.com/article/912244021-beam-therapeutics-to-present-updated-biomarker-data-from-phase-1-2-beacon-trial-further-underscoring-risto-cel-s-ability-to-restore-red-blood-cell Health News of Alabama en PressRelease 2026-05-12T13:30:00+00:00 Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026 https://ml.globenewswire.com/media/03af3276-c254-436a-b40d-2ad9a1025f95/small/beamlogo-color-cmyk-jpg.jpg https://www.healthnewsofalabama.com/article/912244194-cogent-biosciences-announces-multiple-presentations-at-the-european-hematology-association-eha-2026-congress Health News of Alabama en PressRelease 2026-05-12T13:30:00+00:00 Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://www.healthnewsofalabama.com/article/912244306-disc-medicine-announces-multiple-presentations-across-portfolio-at-the-european-hematology-association-eha-2026-congress Health News of Alabama en PressRelease 2026-05-12T13:30:00+00:00 Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://www.healthnewsofalabama.com/article/912244316-caribou-biosciences-to-highlight-vispa-cel-and-cb-011-programs-during-oral-presentations-at-the-2026-european-hematology-association-eha-annual Health News of Alabama en PressRelease 2026-05-12T13:30:00+00:00 Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting https://ml.globenewswire.com/media/9cd3169e-5a07-44f7-b820-b6f4fff6e4d1/small/caribou-logo-png.png